Bank of New York Mellon’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.65M | Buy |
114,699
+25,329
| +28% | +$585K | ﹤0.01% | 2606 |
|
|
2025
Q1 | $2.41M | Buy |
89,370
+10,511
| +13% | +$284K | ﹤0.01% | 2588 |
|
|
2024
Q4 | $4.22M | Sell |
78,859
-7,976
| -9% | -$427K | ﹤0.01% | 2371 |
|
|
2024
Q3 | $3.94M | Sell |
86,835
-28,192
| -25% | -$1.28M | ﹤0.01% | 2408 |
|
|
2024
Q2 | $4.82M | Buy |
115,027
+66,340
| +136% | +$2.78M | ﹤0.01% | 2364 |
|
|
2024
Q1 | $1.83M | Sell |
48,687
-4,059
| -8% | -$153K | ﹤0.01% | 2806 |
|
|
2023
Q4 | $566K | Sell |
52,746
-303
| -0.6% | -$3.25K | ﹤0.01% | 3482 |
|
|
2023
Q3 | $535K | Hold |
53,049
| – | – | ﹤0.01% | 3503 |
|
|
2023
Q2 | $630K | Sell |
53,049
-42
| -0.1% | -$499 | ﹤0.01% | 3463 |
|
|
2023
Q1 | $642K | Sell |
53,091
-414
| -0.8% | -$5.01K | ﹤0.01% | 3354 |
|
|
2022
Q4 | $705K | Buy |
53,505
+3,412
| +7% | +$44.9K | ﹤0.01% | 3364 |
|
|
2022
Q3 | $679K | Buy |
50,093
+7,707
| +18% | +$104K | ﹤0.01% | 3397 |
|
|
2022
Q2 | $517K | Sell |
42,386
-3,615
| -8% | -$44.1K | ﹤0.01% | 3559 |
|
|
2022
Q1 | $660K | Buy |
46,001
+9,464
| +26% | +$136K | ﹤0.01% | 3549 |
|
|
2021
Q4 | $721K | Buy |
36,537
+5,064
| +16% | +$99.9K | ﹤0.01% | 3572 |
|
|
2021
Q3 | $681K | Buy |
+31,473
| New | +$681K | ﹤0.01% | 3624 |
|